PortfoliosLab logoPortfoliosLab logo
ADMA vs. SMNEY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ADMA vs. SMNEY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ADMA Biologics, Inc. (ADMA) and Siemens Energy AG (SMNEY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


ADMA

1D
-1.32%
1M
-3.41%
YTD
-54.99%
6M
-58.49%
1Y
-61.99%
3Y*
27.09%
5Y*
35.16%
10Y*
1.84%

SMNEY

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ADMA vs. SMNEY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
ADMA
ADMA Biologics, Inc.
-54.99%6.36%279.42%16.49%175.18%-27.69%-5.34%
SMNEY
Siemens Energy AG
25.32%167.97%298.17%-29.76%-27.66%-31.90%21.11%

Correlation

The correlation between ADMA and SMNEY is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.08

Correlation (3Y)
Calculated over the trailing 3-year period

0.19

Correlation (5Y)
Calculated over the trailing 5-year period

0.17

Correlation (All Time)
Calculated using the full available price history since Dec 14, 2020

0.18

The correlation between ADMA and SMNEY shifts across timeframes, from 0.08 (1 year) to 0.19 (3 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ADMA:

$1.97B

SMNEY:

$152.45B

EPS

ADMA:

$0.68

SMNEY:

€2.16

PE Ratio

ADMA:

12.13

SMNEY:

81.35

PS Ratio

ADMA:

3.93

SMNEY:

3.93

PB Ratio

ADMA:

5.05

SMNEY:

13.51

Total Revenue (TTM)

ADMA:

$509.86M

SMNEY:

€39.81B

Gross Profit (TTM)

ADMA:

$312.42M

SMNEY:

€7.27B

EBITDA (TTM)

ADMA:

$218.74M

SMNEY:

€4.73B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ADMA vs. SMNEY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ADMA
ADMA Risk / Return Rank: 33
Overall Rank
ADMA Sharpe Ratio Rank: 33
Sharpe Ratio Rank
ADMA Sortino Ratio Rank: 44
Sortino Ratio Rank
ADMA Omega Ratio Rank: 44
Omega Ratio Rank
ADMA Calmar Ratio Rank: 33
Calmar Ratio Rank
ADMA Martin Ratio Rank: 11
Martin Ratio Rank

SMNEY

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ADMA vs. SMNEY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ADMA Biologics, Inc. (ADMA) and Siemens Energy AG (SMNEY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ADMASMNEYDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

0.76

Calmar ratioReturn relative to maximum drawdown

-0.98

Martin ratioReturn relative to average drawdown

-1.95

ADMA vs. SMNEY - Sharpe Ratio Comparison


Loading charts...

Drawdowns

ADMA vs. SMNEY - Drawdown Comparison


Loading charts...

Drawdown Indicators


ADMASMNEYDifference

Max Drawdown

Largest peak-to-trough decline

-91.28%

Max Drawdown (1Y)

Largest decline over 1 year

-63.48%

Max Drawdown (3Y)

Largest decline over 3 years

-68.99%

Max Drawdown (5Y)

Largest decline over 5 years

-68.99%

Max Drawdown (10Y)

Largest decline over 10 years

-86.11%

Current Drawdown

Current decline from peak

-66.50%

Average Drawdown

Average peak-to-trough decline

-53.05%

Ulcer Index

Depth and duration of drawdowns from previous peaks

33.85%

Volatility

ADMA vs. SMNEY - Volatility Comparison


Loading charts...

Volatility by Period


ADMASMNEYDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.74%

Volatility (6M)

Calculated over the trailing 6-month period

45.54%

Volatility (1Y)

Calculated over the trailing 1-year period

54.60%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

59.47%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

69.03%

Dividends

ADMA vs. SMNEY - Dividend Comparison

Neither ADMA nor SMNEY has paid dividends to shareholders.


PositionTTM2025202420232022
ADMA
ADMA Biologics, Inc.
0.00%0.00%0.00%0.00%0.00%
SMNEY
Siemens Energy AG
0.00%0.00%0.00%0.00%0.61%

Financials

ADMA vs. SMNEY - Financials Comparison

This section allows you to compare key financial metrics between ADMA Biologics, Inc. and Siemens Energy AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B20222023202420252026
114.49M
9.68B
(ADMA) Total Revenue
(SMNEY) Total Revenue
Please note, different currencies. ADMA values in USD, SMNEY values in EUR

ADMA vs. SMNEY - Profitability Comparison

The chart below illustrates the profitability comparison between ADMA Biologics, Inc. and Siemens Energy AG over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-20.0%0.0%20.0%40.0%60.0%80.0%20222023202420252026
70.5%
21.6%
Portfolio components
ADMA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a gross profit of 80.75M and revenue of 114.49M. Therefore, the gross margin over that period was 70.5%.

SMNEY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Siemens Energy AG reported a gross profit of 2.09B and revenue of 9.68B. Therefore, the gross margin over that period was 21.6%.

ADMA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported an operating income of 58.27M and revenue of 114.49M, resulting in an operating margin of 50.9%.

SMNEY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Siemens Energy AG reported an operating income of 962.00M and revenue of 9.68B, resulting in an operating margin of 9.9%.

ADMA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a net income of 45.33M and revenue of 114.49M, resulting in a net margin of 39.6%.

SMNEY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Siemens Energy AG reported a net income of 677.00M and revenue of 9.68B, resulting in a net margin of 7.0%.


Frequently Asked Questions


ADMA and SMNEY have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for ADMA and SMNEY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer